Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM
GERMANTOWN, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ:ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today announced it ranked 171 on the Deloitte Technology Fast 500™, a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 29th year.
Related news for (ORGS)
- Orgenesis Provides Third Quarter 2024 Business Update
- orgenesis commences trading on otcqx® best market
- orgenesis announces reverse stock split
- orgenesis announces positive results from a real-world study of org-101 car-t therapy in patients with cd19+ acute lymphoblastic leukemia
- Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic